ECONOMIC ANALYSIS OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN MEXICO

被引：1
|
作者：
Reyes-Lopez, A. [1 ]
Lemus, A. [2 ]
Acevedo, G. A. R. [3 ]
机构：
[1] Children Hosp Mexico, Mexico City, DF, Mexico
[2] Sanofi Aventis Mexico, Mexico City, DF, Mexico
[3] IMSS, Hosp Carlos Mc Gregor Sanchez Navarro, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75017-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A408 / A409
页数：2
相关论文
共 50 条
  • [1] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    [J]. DIABETOLOGIA, 2011, 54 : S420 - S421
  • [2] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [3] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Yoshiki Kusunoki
    Tomoyuki Katsuno
    Kana Miyakoshi
    Takashi Ikawa
    Rie Nakae
    Fumihiro Ochi
    Masaru Tokuda
    Takafumi Akagami
    Kazuki Murai
    Masayuki Miuchi
    Tomoya Hamaguchi
    Jun-ichiro Miyagawa
    Mitsuyoshi Namba
    [J]. Diabetes Therapy, 2013, 4 : 461 - 472
  • [4] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Miyakoshi, Kana
    Ikawa, Takashi
    Nakae, Rie
    Ochi, Fumihiro
    Tokuda, Masaru
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    [J]. DIABETES THERAPY, 2013, 4 (02) : 461 - 472
  • [5] COMPARATIVE STUDY OF ANNUAL TREATMENT COST OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Sil, M. J. S. A.
    Acevedo, G. A. R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A507 - A507
  • [6] Costs analysis of type 2 diabetes mellitus treatment with insulin glargine or detemir
    Alvarez Guisasola, F.
    Mauricio Puente, D.
    Garcia Coscolin, T.
    Betegon Nicolas, L.
    Rubio-Terres, C.
    [J]. AVANCES EN DIABETOLOGIA, 2010, 26 (06): : 430 - 435
  • [7] COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR
    Guisasola, Alvarez F.
    Puente, Mauricio D.
    Coscolin, Garcia T.
    Terres, Rubio C.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A287 - A287
  • [8] A meta-analysis of clinical therapeutic effect of insulin glargine and insulin detemir for patients with type 2 diabetes mellitus
    Zhuang, Y. G.
    Peng, H.
    Huang, F.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (19) : 2566 - 2570
  • [9] Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
    Kabadi, Udaya M.
    [J]. CLINICAL DRUG INVESTIGATION, 2008, 28 (11) : 697 - 701
  • [10] Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
    Udaya M. Kabadi
    [J]. Clinical Drug Investigation, 2008, 28 : 697 - 701
12345